Update:
The Ontario government unveiled today the second round of research projects approved and supported through the $20 million Ontario COVID-19 Rapid Research Fund.
The goal is for researchers to be able to find ways to prevent, detect, and treat COVID-19.
Selected projects include:
- The Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC) Trial: A Multinational Randomized, Adaptive, Controlled Clinical Trial – Support for Personnel at the International Clinical Coordinating Centre in Ontario, Patrick Lawler, Principal Investigator, University Health Network
- Development and Validation of Flexible Medium Throughput Solutions for COVID-19 Diagnostics, Myron Cybulsky, Principal Investigator, University Health Network
- Ontario’s Response to COVID-19: Balancing Trade-offs and Improving Outcomes for all Ontarians, Beate Sander, Principal Investigator, University Health Network
- How to Re-open Ontario’s Economy Without Causing a Resurgence of COVID-19, Chris Bauch, Principal Investigator, University of Waterloo
- Proposal for Validation of a New SARS-CoV-2 Diagnostic Test Enabling Safe, At-home Collection and Increased Provincial Testing Capacity, Katherine Siminovitch, Principal Investigator, Sinai Health System
- Canadian COVID-19 Emergency Department Rapid Response Network – Ontario Sites, Steven Brooks, Principal Investigator, Queen’s University
- Ontario Healthcare Worker Seroprevalence of Anti-SARS-CoV-2 Antibodies (COVID-19 Antibodies in Ontario Healthcare Workers), Michelle Science and Aaron Campigotto, Co-Principal Investigators, Hospital for Sick Children
- Interferon Lambda for Immediate Antiviral Therapy at Diagnosis (ILIAD): A Phase II Randomized, Open-label, Multicenter Trial to Evaluate the Effect of Peginterferon Lambda for the Treatment of COVID-19, Jordan Feld, Principal Investigator, University Health Network
- Natural Evolution of Serum Antibodies in Children and Adults with SARS-CoV-2 and Household Contacts, Maala Bhatt and Roger Zemek, Co-Principal Investigators, Children’s Hospital, Eastern Ontario Research Institute
- Development of Multiple Vaccine Candidates for SARSCoV-2 and Evaluation of Safety and Efficacy in Animal Models, Rob Kozak, Principal Investigator, Sunnybrook Health Sciences Centre
- Adaptive Immunity and Outcomes of Convalescent Plasma, Rulan Parekh, Principal Investigator, Hospital for Sick Children
- Methylene Blue-mediated Photodisinfection for SARSCoV-2 in the Upper Respiratory Tract, Cari Whyne, Principal Investigator, Sunnybrook Research Institute
- Development of High Throughput, Inexpensive and Scalable Testing to Detect SARS-CoV-2 Antibodies Using Home Blood Collection Kits and a Fully Automated ELISA Antibody Assay, Keith Jarvi, Principal Investigator, Sinai Health System
- An Optimized Clinical Lab COVID-19 Diagnostic Test Incorporating Host Transcriptomic Responses for Predicting Disease Course and Healthcare System Utilization, Jeremy Hirota, Principal Investigator, McMaster University
- Toolkit to Prevent COVID-19 Transmission among Persons with Dementia in Long-Term Care, Andrea Iaboni, Principal Investigator, University Health Network
- Creating an N95 Respirator Disinfection to Protect Front Line Health Care Workers During the COVID-19 Pandemic, Gregory Borschel, Principal Investigator, Hospital for Sick Children
- RdRp as a Promising Target to Identify Lead Compounds for the Treatment of COVID-19: a Rapid Structure-Based Approach, Gennady Poda, Principal Investigator, Ontario Institute for Cancer Research
- Co-creating Innovative Strategies to Address the Well-being of Older Persons and Their Healthcare Providers During the COVID-19 Pandemic, Sepali Guruge, Principal Investigator, Ryerson University
- Control of COVID-19 Outbreaks in Long-Term Care: A Randomized Controlled Trial of Chemoprophylaxis to Control Outbreaks of COVID19 in Long Term Care Facilities (CONTROL-COVID), Allison McGeer, Principal Investigator, Lunenfeld Tanenbaum Research Institute, Sinai Health System
- Proposal for the Use of Inhaled Anesthetic-Based Sedation in Ventilated COVID-19 Patients: Novel Approach to Shorten Duration of Ventilation, Preserve Intravenous Sedation Stocks and Improve Survival, Marat Slessarev, Principal Investigator, Lawson Health Research Institute
Original story:
Premier Doug Ford is slated to make an announcement at 1:00 p.m. today at the Medical Innovation Exchange in Kitchener, Ontario.
The news conference comes just one day after the federal government confirmed they would be providing $7B in funding to Ontario.
Ford will be joined by Vic Fedeli, Minister of Economic Development, Job Creation and Trade, and Ross Romano, Minister of Colleges and Universities, to make the announcement.
Village Media will carry the livestream, so stay tuned.
